Illumina Q3 Sales Rise 50 Percent on 'Substantial' Demand for Arrays, Sequencers

Array sales were led by the firm's Omni 2.5-Quad, which became Illumina's "best-selling array in its first full quarter of shipment."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.